Early Access Program for Zolbetuximab - Join Clinical Trial NCTNCT06048081
How to Join This Clinical Trial - NCTNCT06048081
Learn how to participate in this Not Specified trial studying an investigational therapy for Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma Cancer, Metastatic Gastric Adenocarcinoma Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma. Current status: AVAILABLE.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma Cancer, Metastatic Gastric Adenocarcinoma Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma Cancer, Metastatic Gastric Adenocarcinoma Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
- Treatment Being Tested
- Investigational treatment
- Study Phase
- Not Specified - Research study
- Enrollment Status
- AVAILABLE
- Study Identifier
- NCTNCT06048081 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 140 locations. Find a study site near you:
Clinical Research Site
Morristown, New Jersey 07960 - United States
Status: AVAILABLE
Clinical Research Site
Belém, - Brazil
Status: AVAILABLE
Clinical Research Site
Belo Horizonte, - Brazil
Status: AVAILABLE
Clinical Research Site
Brasília, - Brazil
Status: AVAILABLE
Clinical Research Site
Florianópolis, - Brazil
Status: AVAILABLE
Clinical Research Site
Londrina, - Brazil
Status: AVAILABLE
Clinical Research Site
Manaus, - Brazil
Status: AVAILABLE
Clinical Research Site
Natal, - Brazil
Status: AVAILABLE
Clinical Research Site
Porto Alegre, - Brazil
Status: AVAILABLE
Clinical Research Site
Rio de Janeiro, - Brazil
Status: AVAILABLE
And 130 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this Not Specified clinical trial for Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma Cancer, Metastatic Gastric Adenocarcinoma Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships